| Date | Title | Description |
| 05.11.2024 | FWD Group announces strong new business growth update | HONG KONG, Nov. 5, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced strong new business growth highlights for the nine months ended 30 September 2024.
Value of new business (VNB) of ... |
| 04.11.2024 | Book review: DeepTech PlayBook by Patrick Griss |
Patrick Griss’ book addresses any entrepreneur who seeks to transform scientific research into a successful startup. Whether they are just forming a business idea or have already progressed to developing prototypes, the book provides a gui... |
| 01.11.2024 | Swiss ingenuity shines on TIME's Best Inventions 2024 list |
TIME has included five Swiss innovations on its latest list of 200 best inventions. Notably, four of these originate from young companies. They are active in a diverse range of sectors, including medtech, cleantech and sport, reflecting th... |
| 31.10.2024 | Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease | New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s disease related amyloid pathology with very good accuracy.In the largest worldwide clinical trial of its kind, the bl... |
| 29.10.2024 | Tolerance Bio: $17.2 Million (Seed) Raised To Increase Healthspan By Manipulating Thymus Functions | Tolerance Bio, a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance, announced the closing of its ov... |
| 24.10.2024 | Sidero Labs Secures $4 Million to Simplify Kubernetes Management | In the fast-paced world of technology, Sidero Labs has emerged as a beacon for companies grappling with the complexities of Kubernetes and container management. On October 23, 2024, the San Francisco-based startup announced it had raised $4... |
| 24.10.2024 | Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award" | SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- The 17th "C.C. Tan Life Science Award" ceremony was held in Shenyang, China, on October 9th. Dr. Li CHEN, Founder and Chief Executive Officer of Hua Medicine, was awarded the "C.C. Tan ... |
| 23.10.2024 | Sidero Labs Raises $4.0M in Funding | Sidero Labs, a San Francisco, CA-based software developer focused on providing solutions to help lower the friction in managing Kubernetes and containerized applications, raised $4.0M in funding.
The round was led by Hiro Capital with parti... |
| 23.10.2024 | Sidero Labs raises $4M to advance Kubernetes and bare-metal cluster management solutions
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mis... | Kubernetes and containerized application management startup Sidero Labs Inc. announced today that it has raised $4 million in new funding to advance its solutions for managing bare-metal and hybrid computing clusters while ensuring high lev... |
| 22.10.2024 | 【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting | TAIPEI, Oct. 22, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S】Group, recognized for its expertise in cultivating the rare medicinal fungus Taiwanofungus, native to Taiwan, has reached a significant milestone by up... |
| 20.10.2024 | Tolerance Bio: Pioneering the Future of Immune Health with $17.2 Million Seed Funding | In the world of biopharmaceuticals, innovation is the lifeblood. Tolerance Bio, a Philadelphia-based company, has just secured $17.2 million in seed funding. This financial boost is not just a number; it represents a beacon of hope for many... |
| 20.10.2024 | Tolerance Bio: $17.2 Million (Seed) Raised For Increasing Healthspan By Adjusting Function Of The Thymus | Tolerance Bio – a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance – announced the closing of its ... |
| 18.10.2024 | The Microbiome Revolution: Holobiome's $9 Million Leap Forward | In the world of health and wellness, the gut is the new frontier. Holobiome, a microbiome platform company, has just secured $9 million in a Seed funding round. This investment is not just a financial boost; it’s a signal that the microbiom... |
| 18.10.2024 | Consumer groups ask FTC to block Novo Holdings-Catalent deal | Boards, Policy & RegulationMergers & Acquisitions
Regulatory Oversight
Corporate Counsel
Health
Consumer groups ask FTC to block Novo Holdings-Catalent deal
By Jody Godoy and Maggie FickOctober 17, 20249:55 PM UTCUpdated ago
Text
Sm... |
| 17.10.2024 | Insights to Conducting Clinical Trials in Africa - A Shared Experience, Upcoming Webinar Hosted by Xtalks | www.p-95.com
In this free webinar, learn about the advantages and challenges of conducting clinical research in Africa. Attendees will learn how to enhance patient recruitment by accessing diverse and accessible populations. The featured sp... |
| 11.10.2024 | FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation | Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting1This approval helps addre... |
| 10.10.2024 | The New Age of Analytics: dbt Labs and SAP Lead the Charge in AI-Driven Collaboration | In the fast-paced world of data analytics, innovation is the lifeblood that keeps organizations thriving. Two major players, dbt Labs and SAP, have recently unveiled groundbreaking advancements that promise to reshape the landscape of analy... |
| 09.10.2024 | Basecamp Research raises $60M Series B to fuel AI advancements in life sciences | Basecamp Research, an AI company dedicated to solving the most pressing challenges in the life sciences today announced it has completed a $60 million Series B financing led by Singular, bringing its funding to date to to $85 million.
Basec... |
| 09.10.2024 | dbt Labs Unveils AI Innovations and New Features to Improve Collaboration and Multi-platform Analytics | One dbt unlocks the potential of the Analytics Development Lifecycle
dbt Labs, the pioneer in analytics engineering, announced new features and enhancements to dbt Cloud, cementing the platform as the data control plane for enterprise analy... |
| 08.10.2024 | Eldico secures new funding to drive global expansion and enhance commercial operations | Venture Kick alumnus Eldico, founded in 2019 at Switzerland Innovation Park Innovaare, has become a leader in electron diffraction with its ELDICO ED-1 electron diffractometer. This technology accelerates nano-crystalline material analysis,... |
| 08.10.2024 | Eldico secures fresh funding to fuel global expansion |
Founded in 2019 and based at the Switzerland Innovation Park Innovaare at the Paul Scherrer Institute, ELDICO has quickly established itself as a leader in electron diffraction. The company's flagship product, the ELDICO ED-1 electron diff... |
| 04.10.2024 | Caelum Diagnostic Solutions: Accelerating Cancer Care by Providing Immediate Diagnostic Biopsy Results | Biopsy Results in 5 minutes
Contact details: Tel: 917-684-8325 E-mail: rwellner@caelumds.com
Contact details Tel: +1-760-685-1411 E-Mail: Media@CaelumDS.com
Caelum Diagnostic Solutions, Inc. has produced the RPIDx, a desktop-sized device th... |
| 02.10.2024 | APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024 | BANGKOK, Oct. 2, 2024 /PRNewswire/ -- The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Alliance's inaugural "Hep-Free: Eliminating Asia's Silent P... |
| 01.10.2024 | Mindpeak Secures $15.3 Million to Transform Cancer Diagnostics | In the realm of healthcare, innovation is the lifeblood that drives progress. Mindpeak, a Hamburg-based company, has just injected a fresh dose of capital into its mission to revolutionize cancer diagnostics. The company recently announced ... |
| 30.09.2024 | Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer | Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor is also eligible to receive additional cash payments contingent on achieving future development, regulatory and commercial m... |
| 30.09.2024 | Mindpeak: AI-Based Pathological Solutions Secures $15.3 Million (Series A) | Mindpeak, a leader in AI-powered pathological solutions, announced it has raised $15.3 million in a Series A funding round. This funding round was led by ZEISS Ventures and InnoVentureFund, with participation from AI.FUND, the European Inno... |
| 30.09.2024 | PeriVision in the fast lane |
Since the FDA registration of its first medical software VisionOne, everything has accelerated for PeriVision. In line with its plans, this summer the Swiss eye care start-up signed a distribution agreement with Von Hoff, one of the leadin... |
| 26.09.2024 | Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis | Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis The REGENCY study met its primary endpoint, demonstrating statistically significant and clinically meaningful t... |
| 23.09.2024 | ISG Digital Business Summit to Explore AI’s Impact on CX | Leaders with Airbus, Swiss Re, Roche, Post Office Group and other companies will gather for the third annual ISG Digital Business Summit DACH, October 7–8, in Frankfurt to discuss their plans and expectations for AI and other emerging techn... |
| 19.09.2024 | A New Dawn in Kidney Cancer Treatment: Roswell Park's Breakthrough Regimen | In the realm of cancer treatment, hope often flickers like a candle in the dark. But recent findings from Roswell Park Comprehensive Cancer Center have ignited a brighter flame for patients battling metastatic kidney cancer. At the European... |
| 19.09.2024 | Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses | Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment of a respiratory viral illness has demon... |
| 19.09.2024 | 2024 ISPE Pharma 4.0™ and Annex 1 Conference Featured Speakers Are Announced | The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually.
The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually.
NORTH BETHES... |
| 18.09.2024 | Tech Park Basel zieht Bilanz |
Der Tech Park Basel ist seit Sommer 2011 in Betrieb. Neben den auf die Nutzung durch junge Technologieunternehmen zugeschnittenen Büro- und Laborflächen stellt der Tech Park Basel auch verschiedene Infrastrukturen bereit und bietet Dienstl... |
| 17.09.2024 | Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring | With this collaboration, Respiree's patient monitoring solution will be made available for healthcare professionals in APAC through a pilot program using Roche's blood glucose monitoring system. The goal is to simplify clinical workflows an... |
| 14.09.2024 | The Intersection of Health and Innovation: A Weekly Snapshot | In the fast-paced world of healthcare, news can feel like a tidal wave. Each week, a multitude of press releases flood the media landscape, highlighting breakthroughs, initiatives, and pressing issues. This week is no different. From advanc... |
| 13.09.2024 | The New Wave of Healthcare Innovation: Leaders Shaping the Future | The healthcare landscape is evolving. Two recent appointments highlight this shift. Closed Loop Medicine and Highlander Health are at the forefront, steering the ship toward a more personalized and efficient future. Closed Loop Medicine, a ... |
| 13.09.2024 | Weekly Recap: 12 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Children's Growth Awareness Week, the effects of climate change on health and new innovations in AI health diagnostics.
NEW YORK, Sept. 13, 202... |
| 13.09.2024 | FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy | Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous
(IV) Tecentriq1,2New subcutaneous (SC) option reduces treatment time to approxima... |
| 12.09.2024 | Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI | SINGAPORE, Sept. 12, 2024 /PRNewswire/ -- Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest diagnostics and life sciences companies in the w... |
| 11.09.2024 | Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors | Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine le... |
| 10.09.2024 | Дешевле, эффективнее и без уколов. Новый «Оземпик» на подходе | Кажется, что человечество стало еще на шаг ближе к исполнению «ленивых желаний». Никаких тренировок, никакой диеты – закинул таблетку и почти безвредно похудел. И если препарат Оземпик стоил дорого и вводился иглой, то теперь на рынке новый... |
| 09.09.2024 | Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing | Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:... |
| 06.09.2024 | Inventive AI: RFP Optimization Platform Raises $4 Million (Seed) | Inventive AI, an AI-based tool for streamlining and optimizing RFP (Request for Proposal) and sales questionnaire workflows, announced the successful closure of its seed funding round, raising $4 million. Sierra Ventures led this funding ro... |
| 05.09.2024 | The Intersection of AI and Culinary Art: A Tale of Two Innovations | In the world of technology and food, two distinct realms are emerging with fervor. One is the realm of artificial intelligence, where data dances and algorithms weave magic. The other is the culinary landscape, where flavors blend and tradi... |
| 04.09.2024 | John Snow Labs Announces Fifth Annual NLP Summit | John Snow Labs, the AI for healthcare company, announced the program for the fifth annual NLP Summit, taking place virtually September 24-26. The free conference, which attracted over 10,000 attendees last year, is the world’s largest gathe... |
| 04.09.2024 | Success! Cancer Survivor Julia Brookshire and Olympic Swimmer Janel Jorgensen McArdle Successfully Swim "World's Oldest" Hellespont and Dardanelles Open Water Swim | Julia Brookshire and Janel Jorgensen McArdle at the historic Hellespont and Dardanelles swim on August 30th, celebrating Brookshire’s CLL remission and raising funds for Swim Across America.
Swimmer Friends and Colleagues Completed Swim Aug... |
| 04.09.2024 | Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis | New Phase II data show vast majority of patients experiencing no relapses or disability progressionFenebrutinib suppressed acute and chronic MRI lesionsFenebrutinib’s safety profile was consistent with previous and ongoing clinical trials a... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 03.09.2024 | General Anesthesia Drugs Market: Trends, Segmentation, and Future Outlook | Share
Tweet
Share
Share
Email
The global general anesthesia drugs market has been experiencing significant evolution, driven by advancements in medical technology, increasing surgical procedures, and a growing emphasis on patient safety and... |
| 03.09.2024 | Parkinson’s Disease Drug Market: Trends, Growth, and Segmentation | Share
Tweet
Share
Share
Email
Parkinson’s disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, affects millions of individuals worldwide. As the global population age... |
| 03.09.2024 | EPFL startup offering Consulting services gets acquired |
Effixis, founded in 2017 by EPFL alumni, is a consultancy company specializing in artificial intelligence and business solutions. With currently 24 employees, the company offers a comprehensive range of services, including AI education thr... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 02.09.2024 | Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 | SAN FRANCISCO and SUZHOU, China, Sept. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for ... |
| 30.08.2024 | Sergey Baranovskiy Leading a New Wave of Global Pharmaceutical Innovation | Share
Tweet
Share
Share
Email
Presently stationed in the UAE and plotting a strategic foray into the United States, Sergey Baranovskiy is a man who has spent more than a decade orchestrating the direction of pharmaceutical research and deve... |
| 29.08.2024 | Innovent and Lilly: Pioneering Paths in Biopharmaceuticals | In the ever-evolving landscape of biopharmaceuticals, two companies stand out: Innovent Biologics and Eli Lilly. Both are making waves, each with a unique approach to tackling pressing health issues. Innovent, based in Suzhou, China, is car... |
| 29.08.2024 | Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 | SAN FRANCISCO and SUZHOU, China, Aug. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for ... |
| 29.08.2024 | Scots Tech Services Firm Waracle Announces New CEO | Waracle, the Dundee-headquartered tech and digital developer, will welcome David Tuck, former group chief executive of digital transformation consultancy Kin + Carta, to the business in early September.
He succeeds chief executive Chris Mar... |
| 28.08.2024 | Innovent Announces 2024 Interim Results and Business Updates | Strong commercial performance and significant pipeline milestones
support sustained growth and innovation
SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopha... |
| 27.08.2024 | ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment | BEIJING, Aug. 27, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr. Jim Wu, Chief Executive Officer of ArkBio, gave an ora... |
| 27.08.2024 | Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH | With the option to self-administer, PiaSky® (crovalimab) has the potential to reduce treatment burden for people with paroxysmal nocturnal haemoglobinuria (PNH) in Europe and their caregiversApproval is based on COMMODORE 2, where subcutane... |
| 26.08.2024 | Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor | Appoints Axel Bolte, MBA, MSc, to Board Director and Stephanie Oestreich, PhD, MPA, to Board Observer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–August 26, 2024–
Opna Bio announced that it has dosed the first patient with OPN-6602, a poten... |
| 13.08.2024 | Myrobalan Therapeutics: Additional $9 Million Raised And Grant Bogle Joins Board | Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system (CNS) conditions, announced the appointment of Grant C. Bog... |
| 13.08.2024 | Takeda, Roche, and Genentech Recognized by the Healthcare Businesswomen's Association for Advancing Women in the Workplace Initiatives | UCB Transformational Program Also Honored
FAIRFIELD, N.J., Aug. 13, 2024 /PRNewswire/ -- To showcase the impactful commitment and outcomes of equitable practices for women in the workplace, the Healthcare Businesswomen's Association (HBA) t... |
| 12.08.2024 | Symbiotic Capital: Life Science Credit Firm Raises Over $600 Million | Global life science credit firm Symbiotic Capital has been officially unveiled with more than $600 million in capital committed and targeted for investments and co-investments. Symbiotic Capital is affiliated with Bellco Capital, a Los Ange... |
| 09.08.2024 | Roche намерен продать стартап по сбору данных о раке стоимостью $1,9 млрд | В 2018 году компания Roche заплатила $1,9 млрд нью-йоркской компании Flatiron Health, чтобы ускорить разработку ею противораковых препаратов и поддержать ее усилия по установлению цен на них в зависимости от эффективности их работы.
В сообщ... |
| 05.08.2024 | Drei Startups mit Mission Markteintritt in Deutschland |
Urban Connect ermöglicht es Unternehmen, nachhaltige Mitarbeitermobilität auf eine neue Art und Weise zu fördern. Seine B2B-Lösung bietet Unternehmen und deren Angestellten den Zugang zu einem vollständig integrierten Ökosystem von geteilt... |
| 05.08.2024 | Lupin completes Phase-III global trial on biosimilar of Lucentis | Drugmaker Lupin has completed advanced clinical trials (Phase III) of its biosimilar version of Roche’s Lucentis (ranibizumab), used to treat age-related macular degeneration (AMD).
About 600 patients from India, the US, the European Union ... |
| 03.08.2024 | Tech Giants Stumble as Pharma Industry Rises in Germany | July 2024 was a month of turbulence for the tech giants. The once soaring market caps of companies like Alphabet and Microsoft took a nosedive. Investors, once enamored with the promise of artificial intelligence, began to question the sust... |
| 02.08.2024 | OutSystems Unveils Speaker Line-Up at ONE Conference | Industry leaders from Axos Bank, Bosch, Carrefour, Gartner, Roche and more to participate in 2024 speaker program
SINGAPORE, Aug. 2, 2024 /PRNewswire/ -- OutSystems, a global leader transforming how companies innovate through software, toda... |
| 01.08.2024 | Tech giants faced major market cap drop in July on earnings worries | Previous
FILE PHOTO: Figurines with computers and smartphones are seen in front of Alphabet logo in this illustration taken, February 19, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
FILE PHOTO: A view shows a Microsoft logo at Microsof... |
| 01.08.2024 | Germany Attracts Another Billion-Euro Pharma Project | French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main.
BERLIN, Aug. 1, 2024 /PRNewswire/ -- Sanofi says the expansion will encompass ar... |
| 01.08.2024 | Curis Provides Second Quarter 2024 Financial and Operating Update | EC Grants ODD to emavusertib in PCNSL
Management to host conference call and webcast today at 8:30 a.m. ET
LEXINGTON, Mass., Aug. 1, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emav... |
| 30.07.2024 | The Future of Order Management: AI's Role in Streamlining Business Operations | In the fast-paced world of business, efficiency is king. Companies juggle a myriad of customer orders daily, often through a chaotic mix of emails, PDFs, and voice messages. This jumble creates bottlenecks, slowing down the entire process. ... |
| 30.07.2024 | European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO) | Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept, and robust retinal drying with VabysmoAdditional submitted ... |
| 30.07.2024 | BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors | WESTBURY, N.Y., July 30, 2024 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Dir... |
| 29.07.2024 | Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care | The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances.LumiraDx’s transformative Point of Care solution will complement Roche’s diagnostics portfolio across Clinical Chemistry, Immun... |
| 29.07.2024 | Global Icon Malala Yousafzai to Headline APACMed's MedTech Forum in Singapore | SINGAPORE, July 29, 2024 /PRNewswire/ -- APACMed is thrilled to announce that Nobel Laureate and global icon Malala Yousafzai will take centre stage at this year's MedTech Forum, taking place on September 5th and 6th at the Suntec Conventio... |
| 29.07.2024 | Mit KI-Mitarbeiter «Adam» Bestellungen schneller bearbeiten |
In Unternehmen, die täglich Kundenbestellungen oder Anfragen in unterschiedlichster Form - von Mails mit der Bestellung im Textfeld oder angehängt als PDF, bis hin zur Bestellaufgabe via Nachricht auf dem Anrufbeantworter – erhalten, ist v... |
| 27.07.2024 | The Future of Diagnostics: Roche's Vision Unveiled at ADLM 2024 | In the bustling heart of Chicago, Roche is setting the stage for the future of laboratory diagnostics. At the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo, the company is showcasing a suite of innovati... |
| 27.07.2024 | The Future of Brain Health: Innovations and Leadership in Alzheimer's and Multiple Sclerosis Treatments | In the ever-evolving landscape of biotechnology, two companies are making waves in the treatment of chronic neurological diseases: Immunic, Inc. and Neurophet. Both are leveraging advanced technologies and seasoned leadership to tackle the ... |
| 26.07.2024 | Advancing Dermatological Research: The American Skin Association's 2024 Grants**
** | ** The American Skin Association (ASA) has taken a bold step forward in the fight against skin diseases. On July 22, 2024, the ASA announced its 2024 research grants, a lifeline for scientists dedicated to understanding and treating skin co... |
| 26.07.2024 | BioVaxys and Innovent: Pioneering New Frontiers in Immunotherapy and Diabetes Treatment**
** | ** In the ever-evolving landscape of biopharmaceuticals, two companies are making waves: BioVaxys Technology Corp. and Innovent Biologics. Each is tackling significant health challenges with innovative approaches. BioVaxys is focused on imm... |
| 25.07.2024 | [Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised | Group sales were up by 5%1 at constant exchange rates (CER) (stable in CHF) in the first half, driven by the high demand for both our medicines and diagnostics; excluding COVID-19-related products, sales increased by 8%
Group sales growth a... |
| 25.07.2024 | Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo | Roche will unveil the next generation of core lab and molecular systems, including a total solution for clinical mass spectrometry.
Attendees can experience firsthand how fully integrated systems and data solutions can streamline lab operat... |
| 24.07.2024 | Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec | – Senior Executive and Thought Leader in Brain Health with Nearly Three Decades of Global Pharmaceutical Experience –
– Served as Neuroimmunology Franchise Head Responsible for Roche's Blockbuster Launch of Multiple Sclerosis Therapy Ocrevu... |
| 23.07.2024 | Erfahrene Expertinnen und Experten verstärken Startup-Management |
Das EHT-Spin-off Riverkin begrüsst mit Nitin Kumar and Marco Adriano Magno zwei neue Mitgründer. Nitin Kumar hat einen Doktortitel in Computational Biology und war an einigen erfolgreichen Startup-Exits beteiligt. Mit diesen Erfahrungen kö... |
| 22.07.2024 | Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA | SAN FRANCISCO and SUZHOU, China, July 22, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatmen... |
| 10.07.2024 | BOLDEN THERAPEUTICS TO PRESENT AT THE 4TH ANNUAL OLIGONUCLEOTIDES FOR CNS SUMMIT | PROVIDENCE, R.I., July 10, 2024 /PRNewswire/ -- Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of CNS illnesses, today announced their invitation... |
| 09.07.2024 | Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes | The Accu-Chek® SmartGuide CGM solution provides 14 days of accurate1 real-time glucose values for adults living with type 1 and type 2 diabetes on flexible insulin therapy.The built-in AI-trained algorithms will empower users to proactively... |
| 08.07.2024 | Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD) | The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeksSusvimo offers the first alternative to regular eye injections that are standard of care for nAMD, which imp... |
| 07.07.2024 | Hainan Free Trade Port deepens cooperation with Switzerland | HAIKOU, China, July 7, 2024 /PRNewswire/ -- A report from Hainan International Media Center (HIMC):
On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland.
From July 4-6, a deleg... |
| 02.07.2024 | Following a strategic pivot, Release Therapeutics hires a new CEO |
Release Tx is developing a proprietary technology capable of delivering highly potent therapeutic proteins beyond the blood-brain barrier (BBB) for the long-term treatment of CNS disorders. Consisting of an macroencapsulation device, that ... |
| 28.06.2024 | Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO) | Positive recommendation is based on two Phase III studies. In addition to robust retinal drying with Vabysmo, these data show early and sustained vision improvements, which are non-inferior to aflibercept If approved, Vabysmo would be the f... |
| 28.06.2024 | CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition | If approved, PiaSky will be the first monthly subcutaneous (SC) treatment for paroxysmal nocturnal haemoglobinuria (PNH) in the EU Additionally, with the option to self-administer, PiaSky may provide an alternative to existing intravenous (... |
| 25.06.2024 | TPG: Significant Strategic Growth Investment In K2 Medical Research | Leading global alternative asset management firm TPG announced a significant strategic growth investment in K2 Medical Research, an integrated clinical trial site platform that specializes in central nervous system (CNS) trials for leading ... |
| 25.06.2024 | Black and Hispanic Patients Face Higher Liver Cancer ED Visits, Study Finds | What You Should Know:
– A new study by Inovalon, a leader in healthcare data analytics, sheds light on racial and socioeconomic disparities in emergency department (ED) visits for patients with hepatocellular carcinoma (HCC), the most commo... |
| 24.06.2024 | Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories | The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care.The new cobas c 703 analytical unit offers industry-leading high... |
| 21.06.2024 | Envision Energy's Path to Net Zero: A Green Revolution Unveiled | Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich, showcasing its remarkable achievements in global decarbonization. This report marks the company's second consecutive... |
| 21.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 21, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich. This report highlights the company's ongoing decarbonization achievements, mar... |
| 20.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 20, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report in Intersolar, declaring its second consecutive year of carbon-neutral operations on a global scale. Th... |
